Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Vladan Vucinic, MD, Sabine Leiblein, PhD, Kristina Schakols, MD, Claudia Nehring, MD, Yvonne Remane, PhD, Madlen Jentzsch, MD, Sebastian Schwind, MD, Wolfram Pönisch, MD, Runa Stiegler, MD, Constanze Kliem, MD, Michael Cross, PhD, Dietger Niederwieser, MD

Blood (2018) 132 (Supplement 1): 2064.

https://doi.org/10.1182/blood-2018-99-118531

Published: 2018

Journal Articles

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Madlen Jentzsch, MD, Elena Ruschpler, Sabine Leiblein, PhD, Yvonne Remane, Jan-Phillip Stümpel, MD, Georg-Nikolaus Franke, MD, Simone Heyn, MD, Nadja Jaekel, MD, Susann Schulze, MD, Song-Yau Wang, MD, Wolfram Poenisch, MD, Claudia Nehring, MD, Sebastian Schwind, MD, Dietger Niederwieser, MD, Vladan Vucinic, MD

Blood (2015) 126 (23): 5439.

https://doi.org/10.1182/blood.V126.23.5439.5439

Published: 2015

Journal Articles

Adverse Immunologic, Cytogenetic, and Molecular Features of AML in Elderly Patients Could Be Overcome by Allogeneic Hematopoietic Cell Transplantation Following Reduced Intensity Conditioning

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Claudia Nehring, Cornelia Becker, MD, Leanthe Braunert, MD, Sabine Leiblein, Jeanett Edelmann, Georg Franke, MD, Wolfram Poenisch, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2011) 118 (21): 3065.

https://doi.org/10.1182/blood.V118.21.3065.3065

Published: 2011

Journal Articles

Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients.

Thoralf Lange, MD, Anja Edelmann, Uwe Siebolts, Claudia Nehring, Nadja Jäckel, Michael Cross, Maier Jacqueline, Dietger Niederwieser, Claudia Wickenhauser

Blood (2010) 116 (21): 3462.

https://doi.org/10.1182/blood.V116.21.3462.3462

Published: 2010

Journal Articles

Monitoring of Incipient Haematological Relapse by CD34 + Donor Chimerism Determination in Patients with Acute Myelogenous Leukaemia and Myelodysplastic Syndrome after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Low Dose TBI-Based Conditioning Regimens.

Dietger W. Niederwieser, Claudia Nehring, Rainer Krahl, Cornelia Becker, Sabine Leiblein, Jeanett Edelmann, Wolf-Dieter Kortmann, Wolfram Poenisch, Thoralf Lange, Haifa K. Al-Ali

Blood (2007) 110 (11): 5033.

https://doi.org/10.1182/blood.V110.11.5033.5033

Published: 2007

Journal Articles

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, PhD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2007) 110 (11): 1654.

https://doi.org/10.1182/blood.V110.11.1654.1654

Published: 2007

Journal Articles

Donor CD34+ Cell Chimerism at Day 28 and Chronic Graft-Versus-Host Disease (GvHD) but Not High-Risk Cytogenetics Influence Outcome of Allogeneic Hematopoetic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, MD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2006) 108 (11): 547.

https://doi.org/10.1182/blood.V108.11.547.547

Published: 2006

Journal Articles

Hematopietic Cell Transplantation after a Low-Dose, Total-Body Irradiation Based Regimen in Elderly Patients with AML: A Multicenter, Multinational, Prospective HOVON/SAKK/OSHO Study.

Dietger Niederwieser, MD, Jan Cornelissen, MD, Haifa-Kathrin Al-Ali, MD, Leo Verdonck, MD, Rainer Krahl, MD, Alois Gratwohl, MD, Claudia Nehring, MD, Cornelia Becker, MD, Wolfram Poenisch, MD, Thoralf Lange, MD, Rainer Storb, MD, Bob Lowenberg, MD

Blood (2006) 108 (11): 321.

https://doi.org/10.1182/blood.V108.11.321.321

Published: 2006

NARROW

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Adverse Immunologic, Cytogenetic, and Molecular Features of AML in Elderly Patients Could Be Overcome by Allogeneic Hematopoietic Cell Transplantation Following Reduced Intensity Conditioning

Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients.

Monitoring of Incipient Haematological Relapse by CD34 + Donor Chimerism Determination in Patients with Acute Myelogenous Leukaemia and Myelodysplastic Syndrome after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Low Dose TBI-Based Conditioning Regimens.

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Donor CD34+ Cell Chimerism at Day 28 and Chronic Graft-Versus-Host Disease (GvHD) but Not High-Risk Cytogenetics Influence Outcome of Allogeneic Hematopoetic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Hematopietic Cell Transplantation after a Low-Dose, Total-Body Irradiation Based Regimen in Elderly Patients with AML: A Multicenter, Multinational, Prospective HOVON/SAKK/OSHO Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only